BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2179909)

  • 1. Chronic myeloproliferative disorders in bone marrow biopsies.
    Georgii A; Vykoupil KF; Buhr T; Choritz H; Döhler U; Kaloutsi V; Werner M
    Pathol Res Pract; 1990 Feb; 186(1):3-27. PubMed ID: 2179909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T; Georgii A; Choritz H
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T; Kern W; Schnittger S; Schoch C
    Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
    Georgii A; Buhr T; Buesche G; Kreft A; Choritz H
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():15-29. PubMed ID: 8951769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathology of Ph1-negative chronic myeloproliferative diseases].
    Georgii A; Choritz H; Büsche G; Kreft A; Buhr T
    Pathologe; 1995 Jan; 16(1):62-9. PubMed ID: 7886016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histomorphologic findings of the bone marrow in chronic myeloproliferative diseases].
    Thiele J; Fischer R
    Z Hautkr; 1989 Oct; 64(10):903-4, 909-12. PubMed ID: 2686247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J; Funke S; Holgado S; Choritz H; Georgii A
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histopathology of chronic myeloproliferative diseases.
    Georgii A; Buesche G; Kreft A
    Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
    Rudzki Z; Papla B; Stachura J
    Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myeloproliferative disorders. The new WHO classification].
    Thiele J; Kvasnicka HM
    Pathologe; 2001 Nov; 22(6):429-43. PubMed ID: 11766643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
    Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.
    Aboudola S; Murugesan G; Szpurka H; Ramsingh G; Zhao X; Prescott N; Tubbs RR; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2007 Feb; 31(2):233-9. PubMed ID: 17255768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM; Thiele J
    Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.